logo

Kura Oncology Inc. (KURA)



Trade KURA now with
  Date
  Headline
5/10/2018 2:26:42 PM Wedbush Is Lowering Kura Oncology Inc. (KURA) FY18 Estimate To -1.89 From -1.50
5/10/2018 2:26:28 PM Wedbush Is Lowering Kura Oncology Inc. (KURA) Q2 18 Estimate To -0.46 From -0.36
3/14/2018 6:34:07 AM Wedbush Is Cutting Kura Oncology Inc. (KURA) FY18 Estimate To -1.50 From -1.34
3/14/2018 6:33:51 AM Wedbush Is Lowering Kura Oncology Inc. (KURA) Q4 18 Estimate To -0.40 From -0.36
3/14/2018 6:33:30 AM Wedbush Is Lowering Kura Oncology Inc. (KURA) Q3 18 Estimate To -0.38 From -0.34
3/14/2018 6:33:18 AM Wedbush Is Lowering Kura Oncology Inc. (KURA) Q2 18 Estimate To -0.36 From -0.33
3/14/2018 6:33:03 AM Wedbush Is Lowering Kura Oncology Inc. (KURA) Q1 18 Estimate To -0.36 From -0.31
12/20/2017 6:26:59 PM Wedbush Starts Kura Oncology Inc. (KURA) At Outperform With $19 Price Target
12/11/2017 10:03:16 AM Kura Oncology Reports New Findings Supporting Development Of Lead Candidate Tipifarnib
10/16/2017 7:37:50 AM Kura Reports Late-Breaking Presentations For Tipifarnib In HRAS Mutant Squamous Head, Neck Cancer And For KO-539 In AML